Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/3 study evaluating golimumab for ulcerative colitis was terminated, and results were posted in 2013.
-
CLINICAL_TRIALS research · 2013-06-05Clinical Trial Update: Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
This clinical trial update reports ongoing data collection on patients treated with the ColonRing circular compression anastomosis device.
-
CLINICAL_TRIALS research · 2013-05-31Clinical Trial Update: Fecal Biomarker Study for Patients With Ulcerative Colitis
A clinical trial update on a fecal biomarker study involving patients with Ulcerative Colitis.
-
FDA approval · 2013-05-15FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi (golimumab) from Janssen Biotech, Inc., expanding the labeling for the product.
-
FDA approval · 2013-05-14FDA Approved: MERCAPTOPURINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for mercaptopurine from Mylan Pharmaceuticals Inc., authorizing a generic version under an appro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluating oral budesonide and rectal hydrocortisone for active ulcerative colitis was terminated; results were posted in 20…
-
FDA approval · 2013-05-03FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for CANASA (mesalamine), indicating a regulatory action to update or expand the product…
-
FDA approval · 2013-04-29FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab from Janssen Biotech, expanding its labeling and indications.
-
FDA approval · 2013-04-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Double Blind Study for the Treatment of Acute Ulcerative Colitis [Phase 3]
Phase 3 double-blind trial update for acute ulcerative colitis; the study sponsored by Warner Chilcott has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. [Phase 1]
Phase 1 study evaluating absorption, metabolism, and excretion of Asacol in children and adolescents with Ulcerative Colitis; the trial stat…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. [Phase 2]
A Phase 2 study evaluating CP-690,550 (tofacitinib) for safety and efficacy in moderate-to-severe ulcerative colitis has completed, with res…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Cannabidiol for Inflammatory Bowel Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating cannabidiol for inflammatory bowel disease, including Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Phase 3]
Phase 3 trial update on a comparative efficacy and safety study in active ulcerative colitis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Phase 3]
Phase 3 comparative efficacy and safety trial in Ulcerative Colitis in remission has completed (status: COMPLETED).
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) [Phase 3]
Phase 3 trial comparing conventional step-up therapy to infliximab monotherapy for ulcerative colitis was terminated; results were posted in…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients [Phase 4]
A Phase 4 clinical trial evaluated the immunogenicity of a Hepatitis A vaccine in patients with inflammatory bowel disease, including Crohn'…
-
CLINICAL_TRIALS research · 2013-02-27Clinical Trial Update: Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A Mayo Clinic-sponsored clinical trial assessed Indigo Carmine staining combined with Narrow Band Imaging to detect dysplasia in colonic muc…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care [Phase 2]
A Phase 2 trial evaluated telemedicine-based outpatient care for inflammatory bowel disease, including ulcerative colitis and Crohn's diseas…
-
CLINICAL_TRIALS research · 2013-02-04Clinical Trial Update: Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis [EARLY_Phase 1]
An early-phase 1 trial is evaluating the effect of Aloe vera on inflammation in patients with mild ulcerative colitis; the current status of…
-
FDA approval · 2013-01-25FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Effect of FAn-7 in UC Activity [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating the effect of FAn-7 on ulcerative colitis activity; current status is unknown.
-
FDA approval · 2013-01-14FDA Approved: BUDESONIDE — Original Application (Oceanside Pharmaceuticals)
FDA approved the original application for budesonide from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis [Phase 3]
Phase 3 study comparing once-daily vs conventional dosing of Asacol (mesalamine) for maintaining quiescent ulcerative colitis; the trial has…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR [Phase 3]
Phase 3 trial FER-IBD-COR evaluating Ferinject (ferric carboxymaltose) for correcting iron-deficiency anemia in inflammatory bowel disease h…